Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept12 oktober 2023Synerkine Pharma, a Dutch biopharmaceutical company creating… https://www.innovationquarter.nl/wp-content/uploads/sites/9/2023/10/synerkine-uitgelicht.jpg 459 1000 linn backegren https://www.iqheadquarter.nl/iq/wp-content/uploads/sites/9/2018/04/afterscroll-site-logo.png linn backegren2023-10-12 14:40:402023-10-12 15:31:50Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept